This acquisition signifies a pivotal moment in healthcare innovation, leveraging Target RWE’s regulatory-grade datasets to address critical gaps in evidence and improve patient outcomes. By combining Target RWE’s capabilities with Highlander Health’s mission-driven leadership, the partnership is poised to set new standards in clinical research and personalized care. This move reflects a broader industry shift toward integrating real-world evidence into drug development and patient care strategies.